Growth Metrics

Inogen (INGN) Capital Expenditures Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -17.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 34.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -6.72%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.89%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -47.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -11.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -43.42%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 27.22%
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn -28.08%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -28.08%
Dec 31, 2025 -92.27%
Sep 30, 2025 -590.76%
Jun 30, 2025 160.58%
Mar 31, 2025 -77.71%
Dec 31, 2024 191.10%
Sep 30, 2024 -103.21%
Jun 30, 2024 -2,358.00%
Mar 31, 2024 1,915.38%
Dec 31, 2023 -219.75%
Sep 30, 2023 292.98%
Jun 30, 2023 -97.67%
Mar 31, 2023 -28.57%
Dec 31, 2022 347.85%
Sep 30, 2022 -258.45%
Jun 30, 2022 -39.01%
Mar 31, 2022 18.18%
Dec 31, 2021 -34.66%
Sep 30, 2021 -62.16%
Jun 30, 2021 363.84%
Mar 31, 2021 -94.79%
Dec 31, 2020 -66.94%
Sep 30, 2020 263.99%
Jun 30, 2020 -228.17%
Mar 31, 2020 58.52%
Dec 31, 2019 -60.35%
Sep 30, 2019 55.37%
Jun 30, 2019 -57.83%
Mar 31, 2019 -55.04%
Dec 31, 2018 491.55%
Sep 30, 2018 -326.94%
Jun 30, 2018 660.45%
Mar 31, 2018 249.92%
Dec 31, 2017 -956.60%
Sep 30, 2017 650.97%
Jun 30, 2017 -185.94%
Mar 31, 2017 -16.95%
Dec 31, 2016 103.10%
Sep 30, 2016 -87.28%
Jun 30, 2016 -92.90%
Mar 31, 2016 29.35%
Dec 31, 2015 -1,642.16%
Sep 30, 2015 342.01%
Jun 30, 2015 1,560.83%
Mar 31, 2015 226.63%
Dec 31, 2014 7.21%
Sep 30, 2014 108.83%
Jun 30, 2014 -90.53%
Mar 31, 2014 -94.66%